Sign In
Buy NBTX
$38.39
-1.77 (-4.41%)
At Close: Jul 31, 2026
PARIS and CAMBRIDGE, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company''), a late-clinical stage biotechnology company pioneering nanoparticl
NANOBIOTIX to Present at the Jefferies Global Healthcare Conference
04:15pm, Thursday, 23'rd May 2024
PARIS and CAMBRIDGE, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company''), a late-clinical stage biotechnology company pioneering physics-bas
Nanobiotix S.A. (NBTX) Q1 2024 Earnings Call Transcript
08:32pm, Wednesday, 22'nd May 2024
Nanobiotix S.A. (NASDAQ:NBTX ) Q1 2024 Earnings Conference Call May 22, 2024 8:00 AM ET Company Participants Craig West - SVP, IR Laurent Levy - Co-Founder and CEO Bart Van Rhijn - CFO Conference Call
NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update
02:00am, Wednesday, 22'nd May 2024
PARIS and CAMBRIDGE, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company''), a late-clinical stage biotechnology company pioneering physics-bas
PARIS and CAMBRIDGE, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company''), a late-clinical stage biotechnology company pioneering nanopartic
NANOBIOTIX to Announce First Quarter Operational and Financial Update on May 22, 2024
04:15pm, Wednesday, 15'th May 2024
Conference call and webcast scheduled on May 22, 2024, at 8:00 am EDT / 2:00 pm CEST Conference call and webcast scheduled on May 22, 2024, at 8:00 am EDT / 2:00 pm CEST
PARIS and CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company''), a late-clinical stage biotechnology company pioneering nanoparticl
Nanobiotix S.A. (NBTX) Q4 2023 Earnings Call Transcript
11:51am, Saturday, 27'th Apr 2024
Nanobiotix S.A. (NASDAQ:NBTX ) Q4 2023 Earnings Conference Call April 25, 2024 8:00 AM ET Company Participants Craig West - Senior Vice President, Investor Relations Laurent Levy - Co-Founder and Chie
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
04:40pm, Wednesday, 24'th Apr 2024
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel radioenhancer NBTXR3 Prolonged survival in Study 10
NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024
04:15pm, Wednesday, 17'th Apr 2024
Conference call and webcast scheduled for Thursday, April 25, 2024, at 8:00 am EDT / 2:00 pm. CEST Conference call and webcast scheduled for Thursday, April 25, 2024, at 8:00 am EDT / 2:00 pm. CEST
PARIS and CAMBRIDGE, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company''), a late-clinical stage biotechnology company pioneering physics-
Nanobiotix to Present at Upcoming Investor Conferences in March
04:15pm, Wednesday, 06'th Mar 2024
PARIS and CAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company''), a late-clinical stage biotechnology company pioneering physics-b
Nanobiotix to Present at the Guggenheim 6th Annual Biotechnology Conference
04:15pm, Wednesday, 31'st Jan 2024
PARIS and CAMBRIDGE, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company''), a late-clinical stage biotechnology company pioneering physics-ba
PARIS and CAMBRIDGE, Mass., Jan. 29, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company''), a late-clinical stage biotechnology company pioneering physics-b
Nanobiotix S.A. (NBTX) Q3 2023 Earnings Call Transcript
01:01pm, Tuesday, 14'th Nov 2023
Nanobiotix S.A. (NASDAQ:NBTX ) Q3 2023 Earnings Conference Call November 14, 2023 8:00 AM ET Company Participants Craig West - Senior Vice President of Investor Relations Laurent Levy - Co-Founder and
